Literature DB >> 15830135

Women with multiple primary breast cancers diagnosed within a five year period, 1994-1998.

Holly L Howe1, Rachel Weinstein, Riaz Alvi, Betsy Kohler, Joellyn H Ellison.   

Abstract

INTRODUCTION: Women diagnosed with a primary breast cancer are at higher risk for a second primary. Few studies have focused on a comparison of women with single breast primary cancers and women with multiple primary breast cancers. The 1994-1998 NAACCR dataset aggregated from high quality registries representing more than one-third of the US population provides a unique opportunity to examine the incidence of multiple primary breast cancers in a large population.
MATERIALS AND METHODS: Using this multi-registry dataset, we describe the incidence pattern of malignant synchronous (within 2 months) and short-term metachronous (from 3 to 60 months) multiple primaries and single primary breast cancers by demographic and tumor characteristics.
RESULTS: Synchronous multiple primary tumors were more similar in age, stage, and tumor grade to single breast tumors than they were to short-term metachronous tumors. The short-term metachronous tumors did not resemble either the synchronous tumors or the single primaries. DISCUSSION: These findings may indicate that while synchronous multiple primaries may have treatment implications different from single primaries, their etiology may be similar to single breast primaries. Further, they may actually be multi-centric single primaries. The two-month interval between multiple primaries is arbitrary and may not distinguish between the synchronous tumors and those occurring within 12 months of the index tumor. The rules for defining and counting breast primaries have implications for interpretation of incidence rates and temporal trends. These data also suggest the need for standard definitions for multiple primary breast tumors among clinicians, pathologists, and surveillance epidemiologists.

Entities:  

Mesh:

Year:  2005        PMID: 15830135     DOI: 10.1007/s10549-004-4258-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  5 in total

1.  Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype.

Authors:  Elżbieta Senkus; Jolanta Szade; Beata Pieczyńska; Anna Zaczek; Joanna Pikiel; Katarzyna Sosińska-Mielcarek; Agnieszka Karpińska; Jacek Jassem
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

2.  Estrogen withdrawal, increased breast cancer risk and the KRAS-variant.

Authors:  Terri P McVeigh; Song-Yi Jung; Michael J Kerin; David W Salzman; Sunitha Nallur; Antonio A Nemec; Michelle Dookwah; Jackie Sadofsky; Trupti Paranjape; Olivia Kelly; Elcie Chan; Nicola Miller; Karl J Sweeney; Daniel Zelterman; Joann Sweasy; Robert Pilarski; Donatello Telesca; Frank J Slack; Joanne B Weidhaas
Journal:  Cell Cycle       Date:  2015-05-11       Impact factor: 4.534

3.  Relation of risk of contralateral breast cancer to the interval since the first primary tumour.

Authors:  C Rubino; R Arriagada; S Delaloge; M G Lê
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

4.  The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre.

Authors:  Terri Patricia McVeigh; Lauren M Hughes; Nicola Miller; Margaret Sheehan; Maccon Keane; Karl J Sweeney; Michael J Kerin
Journal:  Eur J Cancer       Date:  2014-09-15       Impact factor: 9.162

5.  HER2-Positive Metaplastic Spindle Cell Carcinoma Associated with Synchronous Bilateral Apocrine Carcinoma of the Breast.

Authors:  Katsumi Kito; Toshiharu Maeda; Keiko Ninomiya; Atsuro Sugita; Teiri Sagawa; Kinya Matsuoka; Kousei Kinoshita; Naoki Hyodo; Nagisa Morita; Keizo Furuya
Journal:  Case Rep Pathol       Date:  2014-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.